corporatocracy (noun) — a system of government in which corporations, financial institutions, or other business entities hold effective political power, either by directly controlling the state or by exerting decisive influence over the officials and institutions that do.
Five stories landed in the same stretch of July: a lettuce outbreak, an egg outbreak, a thyroid drug that doesn't contain what the label says, an allergy pill cross-contaminated with an entirely different drug, and a coffee chain's own baristas telling the public what their employer wouldn't. It would be easy to blame this on fewer inspectors, and fewer inspectors is a real, documented problem — but it's not the actual weak spot. The weak spot is where inspection happens at all, and what happens to a company after it fails. We check the lettuce after it's already sickened, people. We rarely check the farm where it was grown. And in the entire history of American food safety, there is exactly one case where that failure actually put anyone behind bars.
The Lettuce
An outbreak of Cyclospora — a parasite that causes prolonged, severe diarrheal illness — has now sickened 1,947 people across nine states, with at least 98 hospitalizations. The link: iceberg lettuce grown by Taylor Farms de Mexico, distributed to Taco Bell locations, and sold at retail under Walmart's Marketside brand. Taylor Farms recalled all iceberg lettuce sourced from central Mexico on July 17. That single detail — sourced from central Mexico — is the whole story in miniature. The lettuce was grown on foreign soil, under foreign growing conditions, and the first meaningful safety check most of it received was a lab test run after Americans were already sick.
The Eggs
A separate Salmonella Enteritidis outbreak has sickened at least 98 people across 17 states, with 26 hospitalizations. Midwest Poultry Services, L.P., recalled more than 19 million eggs produced in Texas. This one's domestic, and it matters precisely because it proves the problem isn't simply "foreign bad, American good." Even fully domestic production, inspected under domestic rules, still led to an outbreak that required illness reports — not a routine inspection — to catch.
A separate case shows the same lag from a different angle. Utz recalled select Zapp's and Dirty potato chips back in May over a possible Salmonella risk in a seasoning ingredient — a dry milk powder supplied by California Dairies — issued as a precaution after the ingredient had actually tested negative. It sat as a lower-tier recall for two months, with no confirmed illnesses attached. In July, the FDA reclassified it as Class I, the agency's highest severity tier, reserved for products with a "reasonable probability" of causing serious injury or death — an upgrade triggered by nothing new happening, just a re-read of the same facts. Even when the domestic system catches something before anyone gets sick, it can take months to correctly label how dangerous it actually is.
The Thyroid Drug
Major Pharmaceuticals recalled nearly two dozen lots of levothyroxine sodium — one of the most commonly prescribed drugs in the country — after testing found the tablets "subpotent," delivering less of the drug than the label promises. This outlet could not confirm the manufacturing origin of this specific recalled lot from available public sources, and won't claim more certainty than that. But the broader context is not in question: roughly 80% of the active pharmaceutical ingredient volume used in American generic drugs is manufactured overseas, with India and China together supplying the ingredients behind 60-70% of the generic drugs Americans take. Whatever caused this particular recall, it happened inside a supply chain where the raw ingredient, more often than not, was never made on American soil, and where the FDA's own testimony to Congress has repeatedly flagged foreign manufacturing oversight as a persistent weak point.
The Allergy Pill
On July 18, Unique Pharmaceutical Laboratories — a New Jersey-registered division of the Indian company J.B. Chemicals & Pharmaceuticals, manufactured in Panoli, Gujarat — recalled four lots of generic Zyrtec (cetirizine hydrochloride) after tablets turned up cross-contaminated with ranitidine, an entirely different medication capable of triggering severe hypersensitivity reactions, including anaphylaxis, in sensitized patients. Here's how it was caught: not a lab audit, not an FDA inspection, not the manufacturer's own quality control. A pharmacy technician, filling a routine prescription, noticed red-flecked, discolored tablets that didn't match what a cetirizine pill is supposed to look like — and said something. That is the detection system working exactly as designed: after the product reached a pharmacy shelf, caught by one employee's attention to what a pill is supposed to look like, not by anything upstream of that point.
The Coffee
None of this is confined to food safety agencies. Starbucks Workers United says it has received hundreds of reports from baristas describing sore throats, coughing, chest irritation, and headaches after handling a new silica-based blending powder used in the chain's Blended Refreshers. The ingredient itself, silicon dioxide, is a common food-grade anti-caking agent, and the amorphous form used in food products doesn't carry the same documented lung-disease risk as the crystalline silica dust regulated in industrial settings — that distinction matters, and this outlet isn't going to overstate it. But the pattern holds here too: the entity currently tracking worker complaints and pushing for answers isn't a federal safety regulator. It's the union.
We Inspect the Product. We Rarely Inspect the Source.
Here's the number that should reframe this whole conversation: the FDA physically inspects roughly 1-2% of the food shipments imported into this country every year — some estimates for actual lab sampling run under 1%. That's not a recent cut. A 2010 GAO report already flagged this exact gap, fifteen years before this month's lettuce outbreak. The mechanism that's supposed to cover the other 98-99%, the Foreign Supplier Verification Program, doesn't send American inspectors to foreign farms at all — it requires the importer to verify that its foreign suppliers meet U.S. standards, largely through paperwork and self-reported audits, with FDA auditing only a sample of the importers themselves. That's not a government inspection. That's a company checking its own supplier's homework, with the government checking a fraction of the companies doing the checking.
The Taylor Farms lettuce is the case study. Nobody was inspecting the Mexican fields where it grew, in real time, the way the FDA inspects a domestic packing facility. The system waited for a lab result on the finished, bagged product, after it had already reached 27 states and infected nearly two thousand people. Inspecting the contaminated lettuce after it arrives is not the same thing as inspecting the field, the water source, and the harvest practices that contaminated it in the first place. One of those catches a problem. The other one only measures it.
And this isn't a new complaint dressed up as a fresh one. A January 2025 Government Accountability Office report found the FDA has not met its own mandated inspection targets — domestic or foreign — in any year since 2018. In 2019, the agency's best year on record, the FDA completed just 9% of its 19,200-facility foreign inspection target. By July 2025, actual foreign food facility inspections had fallen roughly 30% below the same period in the two prior years, a decline that GAO and independent reporting both tie to a wave of firings, retirements, and buyouts that hit the agency's investigative support staff hardest. That trajectory means the "few inspectors" problem isn't a recent budget casualty layered on top of a system that otherwise worked. The system was already missing its own targets by double digits before a single position was cut this decade.
It Doesn't Have to Work This Way
Self-verification by importers isn't the only model available — it's a choice, and other wealthy democracies have made a different one. The European Union requires a minimum number of physical checks per year on food entering the bloc, consignment-by-consignment import certificates issued by the exporting country's government, and that its Food and Veterinary Office directly audits the exporting country's food-safety system, not just the individual companies operating within it. That's not a perfect model, and the EU has its own recall history to account for. But it proves "inspect the source, not just the shipment when it lands" is a workable design choice, not a logistical fantasy. Washington built a system that checks the product at the border and takes the exporting company's word on the farm. That was a decision, and it can be different.
This Isn't New. Drugs Have Been Here Before.
If this feels like a familiar shape, it should be. In 2008, contaminated heparin — a blood thinner — killed an estimated 81 Americans and sickened hundreds more after the active ingredient, sourced from a Chinese facility, was found to contain a cheaper counterfeit substance mimicking the real drug. A decade later, in 2018, the FDA recalled more than half the U.S. supply of valsartan, a common blood pressure medication, after finding a probable carcinogen in batches traced to manufacturing plants in China and India — contamination that had likely been entering the U.S. supply since 2014, undetected for roughly four years, because the plant had altered its manufacturing process without the kind of oversight that would have caught it sooner. Both cases share the same structure as this month's lettuce and eggs: the failure occurred at the source, detection came only after people were already harmed, and the fix arrived years, not days, after the exposure began.
Worth being precise about what "inspection" even means here, because food and drugs aren't checked the same way. FDA doesn't inspect drug shipments at the border the way it inspects food — there's no equivalent "percent of imports physically checked" number for medicine. Instead, the FDA approves a manufacturing plant and is supposed to periodically reinspect it. Even by that different yardstick, oversight is thin: as of October 2022, 58% of establishments manufacturing drugs for the U.S. market were located overseas, according to the FDA's own count. Foreign drug facility inspections fell 36% between fiscal 2019 and fiscal 2023. And foreign inspections are typically announced up to 12 weeks in advance, giving a plant months of notice to prepare before FDA investigators arrive — domestic inspections are almost always unannounced. A plant that gets three months' notice and one that gets walked in on cold are not being held to the same standard, and the harder-to-inspect plants are an increasing share of where America's drugs actually come from.
Fines, Not Prison
Here's the accountability gap beneath it all. In 2008 and 2009, peanuts contaminated with Salmonella from the Peanut Corporation of America sickened more than 700 people and killed nine. Company president Stewart Parnell was convicted and sentenced to 28 years in federal prison; his brother and former company vice president, Michael Parnell, got 20 years; and the plant's quality control manager, Mary Wilkerson, got 5 years. It remains the singular case, not the pattern. Despite a steady stream of deadly outbreaks since, no other U.S. food company's executives have served real prison time for similar misconduct. When Blue Bell's listeria-contaminated ice cream was linked to three deaths in 2015, it still took five years before a former company president was even charged. The standard industry consequence for a deadly outbreak is a fine and a recall notice, not a prosecution — and FDA's own follow-through record doesn't help: a federal review of warning letters over contaminated imports found the agency met its own six-month follow-up inspection goal only 11% of the time, and conducted no follow-up inspection at all for 44% of the letters reviewed.
So Who's Actually in Charge?
Put those three facts together, and the staffing-cuts story becomes a secondary problem, not the main one. We inspect only a small fraction of what enters the country at the finished-product stage rather than at the source. The companies that grow and manufacture that product are largely trusted to verify themselves. And when something goes wrong anyway, the near-universal consequence is a bill, not a prosecutor. Fewer inspectors make an already-thin system thinner, and that's real and worth fixing — but hiring back every inspector cut in the last two years would still leave every one of those three structural gaps exactly where they are today. The companies are in charge, functionally, not because anyone conspired to hand them the keys, but because the system was built to check the product at the border and rarely the farm, to take a company's word for its own supplier's compliance, and to treat even a fatal outbreak as a cost of doing business rather than a crime.
Three Honest Ways to Read This
Some of this is just the scale of modern agriculture and pharma, not a conspiracy. Growing lettuce for 27 states and manufacturing generic drugs for the entire country are at a scale where some level of contamination and error is close to unavoidable, foreign supply chain or not.
But the specific numbers here aren't inferred — they're the government's own findings, spanning administrations. The 2010 GAO report on food imports predates the current staffing cuts by fifteen years. The heparin and valsartan cases happened under different presidents. This is a structural pattern, not a partisan one, and pretending otherwise would be dishonest in either direction.
And it's fair to note that every one of these problems eventually got caught, just always after the fact, by patients, by a union, by epidemiologists connecting case counts across states. That the system eventually works as a detection mechanism isn't evidence that it's working as a prevention mechanism. Those are different jobs, and right now only one of them is actually being done.
Corporatocracy is not a market failure. It is the market succeeding — at the wrong thing, for the wrong people, on purpose.
Call to Action: What Needs to Happen Now
- Check your kitchen and medicine cabinet against the specific lot numbers and product names in this piece — the FDA and CDC links have exact identifiers, not just brand names.
- If you or someone in your household takes levothyroxine, call your pharmacist and confirm your lot number isn't on the recalled list.
- If you or someone in your household takes generic Zyrtec (cetirizine hydrochloride, NDC 16571-401-10), check the bottle against recalled lots GY825029 through GY825032 before the next dose.
- Ask your representatives where they stand on shifting food and drug safety enforcement toward source inspection — foreign farms and manufacturing plants, not just the finished product at the border — rather than treating inspector headcount as the whole fix.
- Ask the same question about corporate criminal liability standards for outbreaks that cause serious injury or death. A fine a company can budget for isn't a deterrent. A prosecutor is.
- If you work in food service and you're asked to handle a new ingredient with no clear safety information, you're allowed to ask your employer for the safety data sheet.
Sources
CDC. Salmonella Outbreak Linked to Shell Eggs, Investigation Update (July 2026).
FDA. Midwest Poultry Services, L.P. Recalls Shell Eggs Due to Possible Salmonella Enteritidis Contamination.
CDC. Cyclospora Outbreak Linked to Iceberg Lettuce in 9 States (July 2026).
FDA. Investigation of 9-State Outbreak of Cyclospora Illnesses: Iceberg Lettuce (July 2026).
Taylor Farms. Taylor Fresh Foods Statement Regarding Cyclospora Outbreak.
U.S. News & World Report. FDA: Iceberg Lettuce Recall Stands After False Positive for Cyclospora (July 20, 2026).
HMP Global Learning Network. FDA Issues Class II Recall for Multiple Strengths of Levothyroxine Tablets Due to Subpotency.
American Thyroid Association. FDA Alert for Levothyroxine.
Starbucks Workers United, public statements and worker reports (July 2026), via IBTimes UK coverage.
U.S. Government Accountability Office. GAO-10-699T, Food Safety: FDA Could Strengthen Oversight of Imported Food by Improving Enforcement and Seeking Additional Authorities (2010).
NBC News. U.S. Food Imports Rarely Inspected.
FDA. FSMA Final Rule on Foreign Supplier Verification Programs (FSVP) for Importers of Food for Humans and Animals.
U.S. Government Accountability Office. GAO-21-231, Imported Seafood Safety: FDA Should Improve Monitoring of Its Warning Letter Process and Better Assess Its Effectiveness.
NBC News. FDA Recalls Are a Reminder That China Controls Much of World's Drug Supply.
U.S. Government Accountability Office. GAO-11-95, Food and Drug Administration: Response to Heparin Contamination Helped Protect Public Health.
The Pew Charitable Trusts. Heparin: A Wake-Up Call on Risks to the U.S. Drug Supply (2012).
DrugWatch / ConsumerSafety.org. Valsartan Recall coverage (2018-2019).
U.S. Pharmacopeia, Quality Matters. Over Half of the Active Pharmaceutical Ingredients for U.S. Prescription Medicines Come From India and the European Union.
Food Safety News. Ten Years Later: After PCA, Fines Replaced Prison — and People Paid the Price (2025).
Forensis Group. Peanut Corporation of America Salmonella Outbreak Case Study: Food Safety Enforcement and Executive Convictions.
FoodNavigator. FDA and USDA Staff Cuts Under Trump Raise Food Safety Risks (Feb. 2026).
Investigate Midwest. After USDA Cuts, Complaints Over Food Safety Spike.
U.S. Government Accountability Office. GAO-25-107571, Food Safety: FDA Should Strengthen Inspection Efforts to Protect the U.S. Food Supply (Jan. 2025).
ProPublica. Foreign Food Safety Inspections Hit Historic Low After Trump Cuts (Nov. 2025).
AGDAILY. U.S. Inspections of Foreign Food Facilities Are at Historic Lows.
U.S. Government Accountability Office. GAO-08-794, Food Safety: Selected Countries' Systems Can Offer Insights into Ensuring Import Safety and Responding to Foodborne Illness.
FDA. Unique Pharmaceutical Laboratories (A Div. of J.B. Chemicals & Pharmaceuticals Ltd.) Issues Voluntary Nationwide Recall of Cetirizine Hydrochloride Tablets USP 5 mg Due to Potential Cross Contamination with Ranitidine (July 2026).
Asthma and Allergy Foundation of America. Recall Alert: Prescription Cetirizine Due to Cross Contamination.
Today.com / Fast Company. Utz Potato Chip Recall Receives FDA's Highest Risk Level Due to Possible Salmonella Contamination (July 2026).